Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Lincoln Pharmaceuticals Financial Results

Lincoln Pharmaceuticals reported a consolidated net profit of ₹87.89 Crore for FY26. The board recommended an 18% dividend, signaling consistent shareholder returns and stable growth.

Key figures
Value₹1.80 Cr
Source

BSE filing, NSE: LINCOLN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Lincoln Pharmaceuticals Ltd: key numbers

Share price
₹558.10
Market cap
₹1,118 Cr
Revenue (annual)
₹671.0 Cr
Net profit (annual)
₹87.89 Cr
P/E (TTM)
11.6×Sector 46.1×
Promoter holding
49.78%+0.00% QoQ
FII holding
4.55%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Lincoln Pharmaceuticals Ltd

All →

Other financial results announcements

All →